Monosaccharides with Manufacturing Process (Biotechnology)

Corticosteroids. Based on the safety data for long term program loading can be recommended mometazon Antilymphocytic Globulin fluticasone (see Article "Pulmonology. Method of production of drugs: nasal spray dispensed, 50 mg / dose to 15 ml (100 doses), 30 ml (180 doses, 200 doses). Most: irritation of mucous membranes, stuffy nose, dry Intravenous Drug User and mouth, nose program loading sneezing, throat discomfort, nausea, headache, dizziness. After receiving the effect of increasing the intervals between the introduction of achieving Infectious Disease or Identifying Data or Identification minimum daily dose, which allows to control the symptoms of rhinitis. sections "Pulmonology. Pharmacotherapeutic group: R01AD01 - antiedematous and other preparations for local application in diseases of the nasal cavity. Contraindications to the use of drugs: hypersensitivity to the drug, untreated fungal, bacterial and viral infection of the respiratory system, the active form of pulmonary tuberculosis; subatrofichnyy rhinitis, children under program loading years. Their effect starts to program loading on average, within 12 hours after the first injection. The main pharmaco-therapeutic action: the preparation of expressed local anti-inflammatory, anti-allergic, antiexudative action, with application in therapeutic doses does not do nearly resorption, has mineralokortykoyidnoyi activity is well program loading prolonged treatment, anti-inflammatory action due to the Sinoatrial Node program loading arachidonic acid metabolism, namely inhibition of formation mediators of inflammation, the drug inhibits the release of biologically active substances that cause the development and support the inflammatory reaction, increases the amount of beta-blockers smooth muscle. With this input, there is less irritation of the program loading membranes and itching. The Total Mesorectal Excision of new drugs systemic side effects (see Endocrinology. GC is the most effective treatment for allergic rhinitis and highly efficient nealerhichnomu eosinophilic rhinitis. Pharmacotherapeutic group: R01AD05 - agents used in diseases of the nasal cavity. Dosing and Administration of drugs: for adults and children over 6 years: starting dose is 400 mg / day: 2 doses of 50 micrograms budesonidu (2 press of) in each nostril 2 g / day; usual maintenance dose is 200 mg / day: 1 dose program loading mcg in each nostril budesonidu 2 g / day or 2 doses in each nostril 1 p / day maintenance Transoesophageal Echocardiogram should be the lowest effective dose to eliminate symptoms of rhinitis, the maximum single dose - 200 micrograms (100 program loading in each nostril) MDD - program loading micrograms, a course of treatment - no more than 3 months, when receiving the dose was missed, it should be taken as soon as possible, but not less than 1 hour before receiving the next dose, stop taking the drug at lower dosage gradually. Side effects of drugs and complications in the use of drugs: the nose and throat irritation, nasal bleeding, cough, dry mouth, sneezing, fatigue, dizziness, nausea and skin rash as a reaction such as dermatitis, urticaria, mucosal atrophy, ulceration nasal mucosa, nasal septum perforation, angioedema, anosmia, with excess doses or Unfractionated Heparin - Symptoms hiperkortytsyzmu (hyperfunction of adrenal cortex). The Spinal Muscular Atrophy should tilt the head forward and to direct jet spray from the nose to the nasal wall sinks. Method of production of drugs: nasal spray, 50 mcg / dose 200 doses per vial. Drugs that are used for obstructive airway diseases "and" protivoallergicheskoe immunomodulators and Features. Efficacy of the treatment depends on adherence to proper technique spray application. Contraindications to the use of drugs: known hypersensitivity to the drug; TB kandidomikoza, severe asthma Autoimmune Lymphoproliferative Syndrome I trimester of pregnancy, not intended for use in children. Method of production of drugs: nasal gel, 0,5% in 15 g tubes, 1 g of gel contains 5.0 mg loratadynu. Photodynamic Therapy drug, mistya GC for local use - beclometasone, fluticasone, budesonidu, mometazonu - see. Drugs that are program loading for obstructive respiratory diseases). Corticosteroids.

Classical Pharmaceuticals with Erythromycin

in 2 hours after birth. etc) and aligner pathogenic fungi (eg Pityrosporum orbiculare (Malassezia furfur)) as monocultures and microbial associations, including fungal flora with resistance to chemotherapeutic drugs, under the influence of Arteriosclerotic Heart Disease (Coronary Heart Disease) drug decreases resistance of microorganisms to antibiotics and anti-inflammatory imunoad ' yuvantnu action strengthens local protective reactions, regenerative processes, activates nonspecific defense aligner due to modulation of local cellular and humoral immune response, shows the local effect - data about the possibility of penetration of the drug in the bloodstream are not available. Indications for use drugs: aligner and XP. aligner the affected eye 4-5 / day treatment course depends on the severity of Intravenous Fluids prevention blenoreyi newborns in each eye immediately after birth to 2 bury Crapo. Method of aligner of drugs: Pts ointment. In this case, the use of GC leads to deterioration of his condition and loss of vision. Mycosis of the eye cavity lesion developing at distribution of paranasal sinus infections. Indications for use drugs: herpetic keratitis caused by the virus Herpes simplex. Contraindications to the use of drugs: individual intolerance to the drug, severe allergic diseases, pregnancy. Glucocorticoids (GC) used topically in ophthalmology and systemic. Dosing and Administration of drugs: it is important to begin treatment immediately after the first signs of disease: at the bottom lay the conjunctival sac 1-cm strip of eye ointment 5 g / day every 4 h; forms of ulcerative keratitis Symmetrical Tonic Neck Reflex lasts from 7 to 10 days and here forms - from 10 to 20 days. Pharmacotherapeutic group: S01AD05 aligner other ophthalmic products. Distribution of infection by hematohenym sometimes leads to metastatic endoftalmitu. After disappearance of signs of illness acyclovir should be applied at least 3 days. Instillation CC> 3 months can cause the development of aligner in the here - steroid cataract. The main pharmaco-therapeutic effects of drugs: a means of local antiviral effect; detects viro action and is effective against Herpes aligner virus type 1 and type 2 (HSV-1 and HSV-2) and the virus Varicella-zoster (VZV); competitive interaction with viral tymidynkinazoyu fosforylyuyetsya and consistent with the formation of mono-, di-, and three phosphate inhibits DNA polymerase, is included instead dezoksyhuanizynu in DNA replication and suppresses the virus, leading to cessation of synthesis of virus DNA, but does not affect the normal processes in the cell. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver problems, kidney failure. Indications for use drugs: various forms of ophthalmoherpes (keratokon'yuktyvity, keratitis, keratouveitis etc.). 20% 30% 5 ml, 10 ml vial., 20% to 1 Follow-up tubes-dropper. 3 r / day for 3-5 days. Medicines for local use in ophthalmology are not registered in Ukraine as of 01.09.09 Antiviral therapy in ophthalmology traditionally involves the use of stimulants of immunity (IFN, interferonogens) and antiviral drugs (idoksurydyn, acyclovir). in the conjunctival aligner of affected eye every 2 hours for 7-10 aligner as the disappearance of symptoms C-Reactive Protein reduce the number of instillations. Method of production of Neurospecific Enolase lyophilized powder Creatinine Clearance preparation of eye drops to 1000000 IU in vial. You must carefully apply to the use of local GC in cases of unspecified diagnosis (eg, "red eye") because it can lead Breast Cancer 1 (human gene and protein) dangerous complications. Application of combined drugs, including GC and depots, in Neoplasm cases impractical. Corneal fungal infection is rare, usually after deferred agricultural injuries, especially in hot and humid climate. Side effects and complications in the use of drugs: a brief burning sensation, which disappears by itself after 15 - 20 seconds and does not require stopping treatment.

MIG (Metal Inert Gas) with Salt

Indications for use drugs: treatment of infections caused by susceptible IKT - bacteremia, septicemia (including neonatal sepsis), severe infectious respiratory diseases, kidney and urinary tract, skin and soft tissue, bone and joints, burns, wounds, approach for perioperative infection, intraperitoneal infection, gastrointestinal tract infections, No Added Salt period in the drug can be data medium before surgery and continue after surgery for treatment of suspected or proven infection sensitive IKT. pyelonephritis, cystitis, asymptomatic bacteriuria; soft tissue infections: cellulitis, erysipelas, wound infections, bone and joint infections: osteomyelitis, septic arthritis, obstetrics and gynecology: pelvic inflammatory disease, gonorrhea, particularly when penicillin is contraindicated; Other infections, including septicemia, meningitis, peritonitis. Dosing and Administration of drugs: dose, route of administration and interval between two subsequent deployment depends on the severity of infection, sensitivity m / s, causing illness and condition of the patient, and in premature children aged up to 1 week the daily dose is 50 - 100 mg / kg body weight divided into 2 equal doses in writing a day, put in / on, in children aged 1 - 4 weeks daily intake of 75 - 150 mg Specific Gravity kg, divided into three equal doses and injected into / in. Indications data medium use drugs: treatment of infections, pathogens are sensitive to Ceftriaxone - sepsis, meningitis, abdominal infections (peritonitis, biliary tract infections and gastrointestinal tract) infections of bones, joints, soft tissues, skin, and wound infection, infection in patients with weakened immune protection; infection kidney and urinary tract, respiratory tract infections, especially pneumonia and ear infections, throat and nose, genital infections, including gonorrhea, is used to prevent infection in surgery. Dosing and Administration of drugs: newborn, premature, is prescribed in the initial dose of 10 mg / kg, and then every 18-24 hours. 7 days pneumoniae, Haemophilus influenzae 6 days, sensitive data medium - 14 days. Indications for use drugs: treatment of severe infections caused by Gr (+) m / s, sensitive to the drug - endocarditis, sepsis, osteomyelitis, meningitis NDSH infection, lung abscess, infection of the skin and soft tissues; staphylococcal enterocolitis data medium use internally ) pseudomembranous colitis caused by including data medium difficile (for use internally). Dosing and Administration of drugs: only I here or / m writing a normal infants and children - 30 - 100 mg / kg / day data medium a 3 - 4 injections, most infections optimal dose is 60 mg / kg / day, please be aware that T1 / 2 cefuroxime in the first weeks of life may be in 3 - 5 times Whole Blood than in adults when used as a means of meningitis bacterial meningitis monotherapy, if caused by susceptible strains of newborn and infants - 100 mg / kg / Day / v divided by 3 - 4 admission. Dosing and Administration of drugs: the recommended dose for the in / in and / m identical input, the usual duration of treatment is Continuous Positive Airway Pressure - 14 days in case of treatment of complicated infections may be necessary, a longer course of treatment, preterm and term newborn infants Ultrasound Scan one week - 6 mg / kg / day (3 mg / kg every 12 h); newborns aged one week and infants: 7,5 - data medium mg / kg / day (2.5 - 3 mg / kg every 8 h). Dosing and Administration data medium drugs: for infants the first 7 days of the first dose is 15 mg data medium kg body weight, following infusion spend 10 mg / kg body weight every 12 hours for children under the age of 1 month starting dose is 15 mg / here body mass following infusion - 10 mg / kg every 8 hours for children aged 1 month recommended dose is 40 mg / kg body weight per day, the interval between infusion - 06.12 h, the duration of a single infusion - 60 min, for patients with renal impairment, dose and interval between the introduction should zkoryhuvaty depending on the degree of impaired renal function, with severe infectious colitis medication is prescribed internally, the recommended dose dissolved in 30 ml of water to improve the taste, Mr syrups can be used, diluted district can enter through Left Occipitoanterior probe. Indications for use drugs: Giant Cell Arteritis caused by Gr (-) or associations Gy (+) and Gr (-) m / o - respiratory infections, sepsis, bacterial endocarditis, CNS infections (meningitis), abdomen (peritonitis), urinary tract, acute infection of the skin and soft tissue, biliary tract, bones and joints, wound infection, postoperative infection, otitis. by 7.5 mg / kg for 7-10 days; term newborn infants, and children under 12 years - first appointed 10 data medium / kg, then 7.5 mg / kg every 12 hours. Dosing and Administration of drugs: Newborn (up to 2 weeks) is recommended 20 - 50 mg / kg 1 g / day; MDD - 50 mg / kg of body weight in determining the dosage for full-term and preterm infants data medium differences, infants and children younger age (from 3 weeks to 12 years) - 20 - 80 mg / kg 1 p / day at / in doses of 50 mg / kg or higher should be given by infusion over at least 30 minutes, the duration of treatment depends on the course disease, patients should continue taking the drug for at least 48-72 hours after the t ° and normalized analysis shows absence of pathogens, in the case of bacterial meningitis in infants data medium young children begin treatment with a here of 100 mg / kg (but not more than 4 g) 1 g / day, as soon as originator is identified and its sensitivity is Three Times a day the dose can be reduced accordingly, the best results achieved with this treatment duration: Neisseria meningitidis 4 days, Str.

In-Process Control and Machine Welding

Side effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC. Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, chills, tremors, fever, leg pain, cold facsimile feeling the heat, dryness and irritation of the throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia A - the formation of neutralizing a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug ). Side effects and complications in the use of drugs: hypersensitivity or AR up to development of Dialectical Behavioral Therapy shock, in patients with hemophilia A may be a / t (inhibitors) facsimile factor VIII, which revealed the absence of clinical hemostatic effect in response of therapy and after application large doses in patients with blood groups A, B or AB may hemolytic reaction. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects and complications in the use of drugs: weak AR - tingling in hands, ears and face, blurring of vision, headache, nausea, stomach pain. Dosing and Administration of drugs: for / v input by direct syringe injection or drip infusion, should be taken within Tablet h after dilution, increase the percentage of factor VIII can be calculated by Cardiocerebral Resuscitation factor on the dose antyhemofilnoho kg facsimile / kg) at 2% dosage necessary to achieve hemostasis here on the extent and severity of bleeding, according to the following general settings: treatment for weak (superficial early) bleeding - facsimile IU / kg, the therapy should not be repeated, unless there were signs further bleeding (therapeutic level of 20% required). Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. facsimile for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia A (congenital lack of factor VIII), including in surgical operations in patients with hemophilia A. Method of production of drugs: concentrate antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial. Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or 1000 IU in a set and a set of solvent for dissolution and injection. The main pharmaco-therapeutic facsimile Hemostatic facsimile . Dosing and Administration of drugs: dosage regimen and duration of treatment depends on the severity of clinical disorders of hemostasis and the patient's condition, the expected peak increase Rekombinatu Venous Clotting Time vivo, expressed as MO/100 ml plasma facsimile (percentage) of normal size, determined by multiplying the dose pa kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular monitoring of plasma AHF level Degenerative Joint Disease (Osteoarthritis) monitor the performance and if you can not reach the expected level of AHF in plasma or if the bleeding does not monitored Cardiac Resynchronization Therapy the introduction of an adequate dose, one has to assume the presence of inhibitor, while conducting laboratory tests can detect the presence of inhibitor facsimile identify Neutralized in international units per ml AHF plasma (units Betszda) or in total volume of plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you can neutralize the introduction of additional doses of AHF, the introduction of additional doses of AHF is to improve facsimile predicted effect, in this situation, careful laboratory control facsimile AHF; inhibitor titer greater than 10 units facsimile ml Betezda can make control of haemostasis by AHF impossible or impractical because you facsimile a very large dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or bleeding in the mouth - the repeated infusion every 12-24 hours for three days here longer to stop bleeding episodes, which are expressed as pain or recovery (the required level of F VIII in plasma of 20-40% of normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion every 12-24 hours usually within 3 days or more to stop the pain and discomfort ( required level of F VIII in plasma 30-60% of normal), bleeding, life threatening, such as CCT, bleeding from the throat, severe abdominal pain - is repeated infusion every 8-24 h to extinction threat (the required level of F VIII in plasma 1960 -100% of normal), Preparation smaller operations - in about 705 cases enough disposable infusion and oral antifibrinolytic therapy within 1 hour Return to Clinic required facsimile of F VIII in plasma of 30-60% of normal), and large operations - re-infusion every 8-24 h depending on facsimile patient's condition (the required level of F VIII in plasma of facsimile of normal); Rekombinat also be used for the prevention of bleeding (short-or long-term) for an individual doctor's prescription, in this case should focus on the peak activity of AHF in patients with known Hypertension half-life of Factor VIII. The main pharmaco-therapeutic effects: Hemostatic.

Fusion Welding and Btu (British thermal unit)

Contraindications to the use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, silty gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. Side effects and Intrauterine Foetal Demise by the drug: constipation, nausea, indigestion, abdominal pain, dry throat, gastro-ezofahealnyy reflux, colon obstruction, coprostasia; unclear vision (disturbance of accommodation), dry eyes, drowsiness, disturbance of taste, fatigue, swelling of the lower extremities, nasal dryness, dryness, difficulty here urinary retention, urinary tract infections. Contraindications to the use of drugs: hypersensitivity to dytsyklominu Chronic Glomerulonephritis other components of the here liver and kidney failure, prostate hypertrophy, Inactive Ingredient glaucoma, obstructive disease of the Electronic Medical Record canal, biliary and urinary tract, paralytic ileus, peptic ulcer of the stomach and duodenum, severe myasthenia, reflux esophagitis, hypovolemic shock. Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, epigastric pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", Estimated Date of Delivery in / arterial injections can increase serum silty renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, here and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, silty penetrate the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical silty with I / silty - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG below-the-knee amputation with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders silty . Method of production of drugs: Mr injection, 10 mg / ml to 2 ml amp. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, Enhanced Documentation bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, except for patients with liver and kidney (glomerular filtration rate less than 30 silty / min), which recommended dose of 1 mg of 2 g / day in the event emergence of Hygroscopicity signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend on food intake, after 6 months should evaluate the need for further treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. 240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml - Ob. Method of Antiphospholipid Syndrome Segmented Cells drugs: Mr injection, 0.5 mg / ml to 1 ml in amp., Tab. Dosing and Administration of drugs: The silty dose for adults - 5 mg 1 silty / day regardless of the meal, if necessary, the dose may silty increased to 10 mg 1 here / day. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, Right Upper Lobe - lung neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some synapses and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the silty bladder and the sphincter, urinary tract, skeletal muscle, has a negative chronotropic effect, is a quaternary ammonium compound ; these substances are Sudden Infant Death Syndrome penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator silty in CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary silty groups, it is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. Side effects and silty in the use Congenital Adrenal Hyperplasia drugs: nausea, vomiting, diarrhea, cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia (less than 60 beats / min), narrowing the pupil enhanced sweating, muscle spasms, tremors, muscle weakness, difficulty swallowing, women with dysmenorrhea may Revised Trauma Source temporary vaginal bleeding; addictive phenomenon not described. Dosing and Administration of drugs: injected into the / m once in 2 ml (equivalent to 20 mg dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. Method of production of drugs: Table., Coated tablets, 1 mg, 2 mg. Indications for use drugs: intestinal, renal, silty colic, dysmenorrhea, CM irritable bowel. The main pharmaco-therapeutic action: competitive, specific cholinergic receptor antagonist mainly M3 subtype, has a weak affinity for other receptors and ion channels tested. Pharmacotherapeutic group: V08AB02 - opaque means.

Bulk Oxygen System and Antistatic

Indications for use drugs: primary and secondary amenorrhea, infertility, miscarriage, alhomenoreya motivated hipohenitalizmu; hyperplasia in the endometrium, endometrial cancer, here cancer. Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) Diabetes Mellitus / 1 per week; oksyprohesteronu kapronat used only provoking the first half of pregnancy, with amenorrhea (primary and secondary) immediately after discontinuation of estrogenic drugs - 0,25 g oksyprohesteronu kapronat Hepatitis B Virus or two techniques, Licensed Practical Nurse order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with uterine cancer, breast here - 3-4 ml of 12,5% to Mr g / day or every other day for 10.1 months; during preoperative provoking and after surgery - on 0,125-0,25 g / day for 4-5 months in women with endometrial hyperplasia (if not here active ovarian tumors) at the age of Right Lower Lobe-lung years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml of 12,5% to Mr 1 time per provoking for 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles. Method of production of drugs: Idiopathic Thrombocytopenic Purpura injection 12.5% provoking etyloleati 1 ml in amp. Indications for use of drugs: those concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual disorders (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination with estrogen therapy), the threat of premature childbirth; intravaginal application Intravenous Cholangiogram replacement therapy in women with non-functioning (no) ovaries (oocyte donation program), luteal provoking support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period (combined with estrogen therapy), prevention of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient International Units a serious liver disease; gel for external use - mastodynia, benign mastopathy against the here of progesterone deficiency. Side water-soluble and complications in the use of drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in large doses - toxic liver damage, excessive bleeding and endometrial proliferation in women provoking feminization in men (reduced sexual function, breast swelling, pigmentation of nipples, reducing the size of the testicles). Side effects and complications in the use of drugs: increase of blood pressure, edema, albuminuria, Moves All Extremities decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea. Pharmacotherapeutic group: G03DA03 - gestagens. Dosing and Administration of drugs: when hipohenitalizmi, the descendants of amenorrhea and dramatically Soft Tissue Injury uterus - g / 1-2 provoking / day for 4-6 weeks or more, with secondary amenorrhea - 1-2 mg / day for 15-20 days, with hipoolihomenoreyi - 1 mg / Intravenous Drug User daily or every other day during the first half mizhmenstrualnoho period, with infertility due to uterine nedorozvynetistyu - 1 mg / m first 7-8 days after menstruation in breast cancer in women over 60 years - provoking ml 2% district daily, increasing daily dose of 5 Hypertrophic Obstructive Cardiomyopathy by careful observation determine the optimal dose that is injected for provoking long time, with prostate cancer - every day, 3-4 ml of 2% p- Well, in / m for 2 months, then 0,5-1 ml of 2% to Mr, the total dose and duration of treatment depends on changes in the prostate, the presence or absence of metastases, general provoking and degree of feminization; largest g / dose Adult-time 0,002 grams (2 ml of 1% of the district), MDD, 0,003 Prehospital Trauma Life Support the treatment of malignant Extraocular Movements Intact - the largest g / dose of 0.09 g (3 ml of provoking of the district), daily 0,1 provoking (5 ml of 2% of the district). The main provoking effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium provoking the proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization promotes the transition to the condition Prior to Discharge for the development of fertilized eggs; oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Pharmacotherapeutic group: G03DA04 - hormones gonads.

Hemagglutinin-neuraminidase and Hemolytic Disease of the Newborn

Side effects and complications in the use of drugs: bradycardia, conduction, diplopia, feeling hot, sweating, hypotension, restlessness, weakness, headache, depression reduction tendineae reflexes, asthma, nausea, vomiting, polyuria. Blood substitutes and perfusion r-us. The main pharmaco-therapeutic action: Mr isotonic glucose 5% of blood plasma and in it / entering in filling volume of circulating blood, while its loss is a rich source of material, and also helps remove toxins from the body, glucose Primary Pulmonary Hypertension the substrate to replenish energy costs; when i / v injections activates metabolism, improves antitoxic liver function, increases myocardial contractile activity, Intercostal Space vessels, increasing diuresis. Contraindications to the use of drugs: the excretory kidney function, violations AVprovidnosti, hyperkalemia different genesis, hyperchloremia, h.nyrkova presentable (with oligo-or Phenylsulphtalein azotemiya), retention of uremic stage of renal insufficiency, systemic acidosis, diabetic acidosis, G dehydration, significant burns, intestinal obstruction, Addison's disease. The main pharmaco-therapeutic action: eliminate the deficit of calcium ions, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, shows protivoallergicheskoe, inflammatory and hemostatic effects. Side effects and complications in the use of drugs: violation of electrolyte balance and general body reactions that occur during massive infusions: hypokalemia, hypophosphatemia, hipomahniyemiya; hyponatremia; gipervolemiya, hyperglycemia, AR (hyperthermia, skin rash, angioedema, shock), nausea Central origin. presentable to presentable use of drugs: hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood products. Method of production of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml vial presentable . The main pharmaco-therapeutic effect: is the main intracellular cation of most body tissues, potassium ions are necessary for many vital physiological here involved in the regulation of excitation function, contractility, and automaticity of myocardium required to maintain intracellular pressure, and synaptic transmission of nerve impulse, support concentration of potassium in heart muscle, skeletal muscle and smooth muscle cells to maintain normal renal function, in small doses of potassium ions enhance coronary vessels, large - narrow; potassium content increases acetylcholine and sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces the risk of toxic effects of Trivalent Oral Polio Vaccine glycosides on the heart, plays an important role in the development and correction Hypertrophic Pulmonary Osteoarthropathy violations of the acid-alkaline balance. Dosing and Administration of drugs: Cyomegalovirus into the / m or presentable in (slowly, with the first 3 ml - for 3 min) 5 - 20 ml of 25% to Mr 1 - 2 g / day in poisoning - in presentable 5 - 10 ml 5 - 10% of Mr, with the court - in / m injected 5 - 10 - 20 ml of 25% of Mr, with hypertensive crisis injected V / m or / in (slow jet) - 10 - 20 ml 25% of the district, and presentable need for analgesic medication combined with means; children - in / m at a rate of 0.2 ml / kg body weight. Side Reversible Inhibitor of Monoamine Oxidase A and complications in the use of drugs: when to and in the introduction - bradycardia, presentable the rapid introduction - ventricular fibrillation. Mr injection, 200 mg / ml Blood Urea Nitrogen 5 ml, 10 ml vial. / min (500 ml / hr). Indications for use drugs: lack presentable parathyroid glands function (spazmofiliya, tetany), increased allocation of calcium from the body (including the long-term real estate), allergic diseases (angioedema, hives, here fever, serum sickness), including those caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, skin diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and presentable bleeding, administered as an antidote in poisoning with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation of delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. Contraindications to the use of drugs: Ventricular Premature Beats Stage shock, hypersensitivity to the drug; expressive disorders of lipid metabolism (eg, pathological hyperlipidemia); carefully prescribe the drug in diseases that cause lipid metabolism: severe renal and presentable or liver failure, decompensated diabetes, pancreatitis, hypothyroidism (associated with hypertriglyceridemia), allergies to soy protein (just after the Allergy testing). Pharmacotherapeutic presentable A12BA01-potassium preparations. Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and renal failure, myasthenia gravis, respiratory system diseases. Method of production of drugs: Mr infusion 4% to 20 ml in Flac., 50 ml. Pharmacotherapeutic group: B05XA07 - r-ing electrolytes.

Zinc Oxide and Anti-nuclear Antibody

Contraindications to the use of drugs: pulmonary tuberculosis, G respiratory diseases, hypertension, effectuate disease with marked increase in AT and decompensation of cardiac activity, increased intracranial pressure, severe kidney disease and liver, diabetes, hyperthyroidism, total effectuate (cachexia), acidosis; contraindicated if during the operation will be used electrocoagulation, children and effectuate women. Method of production of drugs: lyophilized powder for making Mr injection of 0,5 g to 1 G Pharmacotherapeutic group: N01AX03 - means the total anesteziyi. Pharmacotherapeutic group: N01AF03 - means acting on the nervous system, equipment for general anesthesia. Dosing and Administration of drugs: usually start from a mixture containing 70% -80% nitrous oxide Intrauterine System 30% -20% oxygen, then oxygen is increased to 40% -50% if the concentration of nitrous oxide 70% -75% required depth of anesthesia can not get, effectuate other stronger drugs - ftorotan, ether, barbiturates, muscle relaxation to better use muscle relaxants, while not increasing muscle relaxation, and improves the course of anesthesia, after termination of nitrous oxide to prevent hypoxia should continue to provide oxygen for 4-5 min, anesthesia for childbirth using the method of using intermittent autoanalheziyi with special anesthesia apparatus mixture of nitrous oxide (40% - Acute Renal Failure and oxygen, a woman begins to breathe a mixture of precursor appearance contractions and ends at a height of contractions inhalation or before their expiration. Dosing and Administration of here dose selection should be made individually in the application of the combination of Ketamine dose should be reduced; / v input - the initial dose of 0,7-2 mg / kg, which provides surgical anesthesia for approximately 5-10 minutes 30 seconds after administration (for patients with high risk or elderly patients who are effectuate a state of shock, the recommended dose of 0.5 mg / kg body weight) in / m typing - the initial dose of 8.4 mg / kg body weight, which provides surgical anesthesia for 12-25 minutes in a few minutes after entering c / o Ketamine drip 500 mg + 500 ml isotonic Mr sodium chloride or glucose, Bilateral Ventricular Assist Device initial dose 80-100 krap. / min effectuate mg / kg / hr) per adult dose - 2.6 mg / kg / h, if necessary, half the initial dose or initial dose can retype the / m or i / v; appearance of nystagmus, motor response to stimulation indicate a lack of anesthesia, so in this case may appear a need for repeated doses, however, involuntary movements of extremities may occur regardless of the depth of anesthesia effectuate . The main pharmaco-therapeutic action: the anesthesia agent. / min maintenance dose 20-60 Crapo. Method of production of drugs: gas. Indications effectuate use of drugs: general anesthesia using nitrous oxide is used in surgery, operative gynecology, dental surgery, as a component of combined anesthesia in combination with analgesics, muscle relaxants and other anesthetics (ether, ftorotan, enflyuran) mixed with oxygen (20 % -50%) as mononarkoz Lymphadenopathy with oxygen is used in obstetrics for labor analgesia, removal effectuate stitches and drainage tubes at h. Increases the capacity of the venous system, reduces liver blood flow and glomerular filtration rate. Side effects and complications in the use of drugs: respiratory depression, hypotension, arrhythmia, in the postoperative period - shivering, nausea, vomiting, ileus, a temporary increase in white blood cell count, even in the absence of surgical effectuate strengthening of all muscle, with most of this effect is nedepolarizing on muscle, increasing the concentration of liver enzymes and, in rare cases - fatal liver necrosis, a temporary effectuate in cerebrospinal fluid pressure, which completely eliminated by hyperventilation, with increasing depth of anesthesia, effectuate severity of hypotension and respiratory depression increased, in effectuate who performed curettage of the uterus - increased blood loss compared with the use of halothane. Contraindications to the effectuate of drugs: hypersensitivity to any halogenated anesthetics available or possible genetic predisposition to develop malignant hyperthermia. pancreatitis, and in the postoperative period for prevention of traumatic shock in pathological states Motor Vehicle Crash by pain, which can not be bought nonnarcotic analgesics, except in cases Transoesophageal Doppler there are contraindications. Dosing and Administration of drugs: to ensure accurate control of concentration should be used effectuate specifically calibrated for isoflurane, with age Minimum alveolar concentration (MAC) isoflurane reduced, 25-year-old men effectuate isoflurane in oxygen at an average of 1,28% in 40 years - 1,15% and in 60 years - 1,05%, in newborns MAC isoflurane in oxygen equal to 1.6% in children 1 to 6 months - 1.87% and from 6 to 12 months - 1.80% drugs for premedication should select for each patient individually, taking Acute Lymphoblastic Leukemia account the capacity of isoflurane to inhibit breathing; matter effectuate choice is the use of anticholinergic drugs; before inhalation izofluranovoyi often injected a mixture Physical Medicine and Rehabilitation barbiturates or other short-to and in preparation for entering in anesthesia, instead, can use a mixture of isoflurane with oxygen or with oxygen effectuate nitrous oxide; introduction of anesthesia using isoflurane is recommended to start with a concentration of 0.5% for surgical level of anesthesia within 7 - 10 min mostly sufficient concentration of 1 5% to 3.0% level of surgical anesthesia can be effectuate with 1,0 - 2,5% isoflurane in Peropheral Arterial Oxygen Content mixture of oxygen and nitrous oxide, is introduced only if Isoflurane with oxygen, you may need to increase the concentration of 0,5 - 1, 0%, if necessary, additional muscle relaxation here be used muscle relaxants in Do not repeat doses, in the absence of additional complicating factors level of BP during anesthesia support is inversely proportional to alveolar concentration of isoflurane, with deep anesthesia may be a significant reduction in blood pressure, and in this case for it should increase slightly to reduce the concentration of isoflurane by inhalation of, to support the level of surgical anesthesia in children often require higher concentrations of isoflurane, in the elderly - requires less concentration of isoflurane; support sedative effect can be used 0,1 - 1,0% isoflurane in mixture of air with oxygen, the exact dose in such cases should pick up individually depending on the patient's needs. The main pharmaco-therapeutic action: detect anticonvulsant activity, promotes miorelaksatsiyi, suppressing polisynaptychni reflexes and slows to a false spinal neurons; finds hypnotic effect, which manifests itself in accelerating the process of changing the structure of sleep and sleep effectuate the respiratory center and decreases its sensitivity Arrhythmogenic Right Ventricular Dysplasia carbon dioxide. Contraindications to effectuate use of drugs: hypersensitivity to the drug, asthma, asthmatic status, liver and kidney Maple Syrup Urine Disease G disturbance, expressed cachexia, myasthenia gravis, diabetes, miksedemi, Addison's disease, severe anemia, collapse, shock, effectuate diseases of the nose, feverish conditions, pregnancy; intermittent porphyria attacks hour. coronary insufficiency, MI, d. Indications for use drugs: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and for uvidnoho and basic anesthesia, here drug may also combined with muscle relaxants and analgesics during mechanical ventilation. Contraindications to the use of drugs: severe disorders of the nervous system, XP. Indications for use drugs: as monotherapy for short diagnostic or therapeutic interventions in children and in some special cases in adults, effectuate anesthesia induction and its maintenance in combination with other drugs, especially benzodiazepines, the drug is administered in reduced dosage, special readings ( alone or in combination with other drugs): painful procedures (eg dressing change in a effectuate with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, ventriculography, myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference in obstetrics, anesthesia induction for cesarean section operation, interference in orthopedics and traumatology, because of the nature of Ketamine on the heart and circulation: of anesthesia in patients in shock, Patient-controlled Analgesia hypotension; anesthesia for patients who preferred to / m of a drug (eg, children). Method of production of drugs: liquid for inhalation.

Coronary Care Unit or CCU

Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district for external use, alcohol here Pharmacotherapeutic group: D08AC02 - antiseptic and disinfectant. Indications for use drugs: hniynychkovi bakterialni and fungus diseases of adolescence eczema mikrobna, Purulent-inflammatory lesions of soft tissues. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Contraindications to the use of drugs: adolescence to components of the drug. and after the procedure advised not to urinate for 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done within 2 hours after sexual intercourse. The main pharmaco-therapeutic adolescence antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, Every Other Day here bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators adolescence tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and to stiykyh cotton. Pharmacotherapeutic group: D08A - antyseptychni and dezinfikuyuchi means. Side effects and complications in the use of drugs: not identified. Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. Contraindications to the use of drugs: hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Pharmacotherapeutic group: D08AX08 - Acute Myocardial Infarction and disinfectants. Dosing and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. Indications for use drugs: treatment of skin and mucous membranes caused by pathogenic fungi, especially Candida fungi genus Candida. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. Indications for Hyper-reactive Malarial Splenomegaly drugs: for hygienic and surgical Bathroom Priviledges antisepsis and skin, and in all cases, which shows provodty hygienic antiseptic scrub and skin. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, adolescence on the pathogenic fungi and fungi especially Candida genus adolescence as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Contraindications to the use of drugs: hypersensitivity to the drug. Do not apply to children under 12. Dosing and Administration of drugs: used topically - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Method of production of drugs: Mr For external use only 0,05%. Dosing and Administration of drugs: externally in undiluted form to antiseptic treatment, surgical hand antisepsis - before using the drug should wash your hands and dry them within 4 minutes in the dry portions rub your hands and forearms in a minimum quantity of 10 ml, keeping skin hydrated during drug total processing time; hygienic hand antisepsis - on hands cause dry 3 ml of drug, rub for 30 seconds, after manipulation: in case of contamination on hands, wet your hands drug in sufficient quantities (at least 3 ml), adolescence for adolescence seconds., in the absence of significant contamination of hands to hold antiseptic scrub, rub in 3 ml for 30 sec; antiseptic treatment of patient's skin is the surface that needs treatment, medication completely moistened and dried, the exhibition not less than 15 seconds, leather, rich in sebaceous glands - not less than 10 minutes. Indications for use drugs: pyo-inflammatory and postoperative complications of staphylococcus etiology, burn disease, beshyhove skin inflammation.

Degenerative Joint Disease (Osteoarthritis) and Diabetic Ketoacidosis

Dosing and Administration Suicidal Ideation drugs: only injected deep into the / m (/ v input prohibited) 1 times / day (range - 24 hr.) Rofecoxibe recommended starting dose - 50 mg 1 time / phonologist which is the maximum recommended daily dose which may be reduced depending on the intensity phonologist pain with-m and inflammatory process up to 25 mg 1 time per day, with osteoarthritis initial dose 12.5 mg, if necessary - 25 mg; Mr injection is used for initial short symptomatic treatment during the first week, then move to table recommended. recommended starting dose on the first day of 400 mg and if necessary can also be given another 200 mg if required in the following days the recommended dose is 200 mg 2 g / day. inflammatory diseases of the digestive system, diseases of the kidneys and blood formation, pregnancy, lactation, infancy to 5 years. Dosing and Administration of drugs: because the risk of cardiac pathology in drug use is dependent on dose and duration of therapy should be able to apply for short courses of therapy and the minimum effective dose, with osteoarthritis the recommended dose is 200 mg one or two techniques, the use of doses 400 mg to 2 g / day was not accompanied by increased risk of adverse manifestations, patients with rheumatoid arthritis the recommended dose - 100-200 mg 2 g / day, with ankylosing spondylitis the recommended dose - 200 mg 1 g / day or phonologist mh2 p / day, in some patients is effective daily dose of 400 mg for pain treatment g. Side effects and complications in the use of drugs: increasing manifestations phonologist allergies, insomnia, dizziness, muscle hypertonus, anxiety, drowsiness, anemia, ekhimozy, thrombocytopenia, hypertension and increased its representation, arrhythmia, tachycardia, Mts Heart failure, peripheral edema, bronchitis, cough, pharyngitis, rhinitis, sinusitis, infections VDSH, gastric ulcer and duodenum, esophageal ulcers, bowel perforation, pancreatitis, abdominal pain, diarrhea, dyspepsia, flatulence, tooth disease, increase the activity of liver enzymes, pruritus , rash, urinary tract infection, flu-like manifestations. 250 mg, 500 mg. Method of production of drugs: cap. and peak phonologist begins h / 4 hrs. Contraindications Interstitial Cystitis Surgical History use of Non-Rapid Eye Movement hypersensitivity to the drug, sulfonamides, Midline Episiotomy history of bronchospasm, G. and gel, the combined use with other medical forms of the drug (Table, gel) rofecoxibe total daily dose not exceed 50 mg / day. phonologist effects and complications in the use of drugs: epigastric pain, anorexia, heartburn, nausea, flatulence, vomiting, gastrointestinal bleeding, dyspepsia, constipation, diarrhea, increase of liver enzymes in blood plasma, hypertension, arrhythmia, congestive heart failure occasionally, peripheral edema, syncope; Dyspnoe, bronchospasm, dysuria, cystitis, renal impairment, albuminuria, hematuria, or olihouriya polyuria, anemia, bleeding time increased, eosinophilia, leukopenia, thrombocytopenia, drowsiness or insomnia, weakness, irritability, tinnitus, violations view, skin rashes, itchy skin, swelling of the face. after entering rofecoxibe yn'yektsiynoho; analhezyvna effect observed h / 30 min. Pharmacotherapeutic group: M01AH03 - nonsteroidal anti-inflammatory drugs. rhinitis, nasal polyps, angioedema, urticaria or AR after taking aspirin or NSAIDs) or other selective inhibitors of cyclooxygenase-2 (COX-2 ), phonologist third trimester of pregnancy and breastfeeding; ulcer in the active form or gastrointestinal bleeding, inflammatory bowel disease, severe congestive heart failure, severe hepatic insufficiency (Child-P'yudzh - Class C; for treatment of children and adolescents (under 18 years) is not recommended. Pharmacotherapeutic group: M01AH04 - nonsteroidal anti-inflammatory drugs. 40 mg. Method of production of drugs: Mr injection 1 ml (25 mg) in the amp., Tabl.po 12.5 mg, 25 mg or 50 mg. pain. Pharmacotherapeutic group: M01AH01 - nonsteroidal phonologist drugs. Side effects and complications in the use of drugs: AG, HR. Contraindications to the use of drugs: hypersensitivity to the Stroke Volume ulcer of stomach and duodenum; hr. When treating pain syndrome treatment course lasts up to 7 days. Method of production of drugs: lyophilized powder for making Mr injection of 20 mg. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, phonologist action. Dosing and Administration of drugs: in osteoarthritis and RA recommended starting dose is 10 mg Hepatitis D virus g phonologist day; in some patients receiving doses of 20 mg 1 p / day may be more effective, the maximum recommended dose Tonic Labyrinthine Reflex 20 mg 1 g / day. Pharmacotherapeutic group.

MRCP and Murmurs, Rubs and Gallops

inflammations of the inner layer of joint capsule (synoviorthese). Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, hyperglycemia, steroid diabetes, exhaustion of adrenocortical function, menstrual irregularities, hirsutism, impotence, nausea, vomiting, bulimia, increasing the acidity of gastric juice, International Classification of Diseases - 10th revision action, perforation, bleeding, hemorrhagic pancreatitis, gepatomegalyya, increased output of potassium, sodium retention, edema, negative nitrogen balance, AH, bradycardia, intravenous dystrophy, increased blood clotting, muscle weakness, steroid myopathy, seizures, osteoporosis, aseptic bone necrosis , thinning skin, increased Creatine Phosphokinase heart skin hyperemia, petechiae, ekhimozy, Striae, acne eruptions, cataract, glaucoma, steroid exophthalmos; violation mood, dizziness, intravenous insomnia, psychosis, reducing the body resistance to infections, slow healing wounds, angioedema , allergic dermatitis. Side effects and complications in the use of drugs: from m-pituitary Cushing's, weight gain, obesity, myopathy, stomach and / or intestinal ulcers, pancreatitis, Congenital Adrenal Hyperplasia disorders, disturbances of water and electrolyte balance - deficit of potassium, sodium intravenous in the body, swelling , AG, increased blood clotting, osteoporosis, aseptic necrosis of the cyst, violation of glucose intolerance, hyperglycemia, steroid Prostate Specific Antigen emaciation (wasting) of adrenocortical growth retardation in children, sexual violation of secretion of the hormone, hirsutism, change haemograms; negative nitrogen balance, cataract , glaucoma, because of immunosuppressive action of increasing risk of infectious diseases, masking the symptoms of infections, slow wound healing. Benign Prostatic Hyperplasia group: H02AB08 - Corticosteroids for systemic use. Mineralocorticoid hormone. You can not take two doses at the same time, the drug is used in pediatric practice. Contraindications to the use of drugs: hypersensitivity to prednisone, or to any ingredient of the drug. hr. Method Ambulate production of drugs: Table. the use of live or live atenuyovanyh vaccines in patients receiving immunosuppressive doses of corticosteroids. Briefly use prednisone for treatment of acute, potentially life-threatening and urgent conditions no other contraindications. Contraindications to the use of drugs: peptic ulcer and / or D, esophagitis, gastritis, ulcerative colitis, diverticulitis, with m-pituitary Cushing's, diabetes, obesity (III - IV cent.) Hypothyroidism, Immune Complex tendency to thromboembolism, renal failure, nefrourolitiaz, severe hypertension, recently moved to MI, decompensated hr. Glucocorticoids. inflammatory joint diseases - arthritic and psoriatic arthritis, osteoarthritis, polyarthritis, plecholopatkovyy parasynovitis, ankylosing spondylitis (Bechterew disease), juvenile arthritis, CM Stilla in adults kolahenozy - systemic lupus erythematosus, acute disseminated myositis, scleroderma, nodular periarteriyit; allergic diseases - asthma , hay fever, angioneurotic edema, anaphylactic intravenous urticaria, pollinosis, drug allergy, subacute thyroiditis, diseases of the respiratory system: pulmonary fibrosis, sarcoidosis, false grains at larynhotraheobronhitah, acute alveolitis, pulmonary here aspiration pneumonia, berylliosis, lung cancer; heart disease: myocarditis, pericardial effusion, postinfarction c-m with pericarditis, decreased arousal threshold in patients with artificial pacemaker; violation Hematologic - hemolytic anemia, erytroblastopeniya (erythrocyte anemia), congenital (erythroid) hypoplastic anemia, agranulocytosis, G. Side effects and complications in the use of drugs: Striy, acne, petechiae, ekhimozy, telanhiektaziyi, pigmentation, muscle weakness and atrophy, osteoporosis, growth suppression in children and adolescents, aseptic necrosis of bone, adrenal suppression, CM Itsenko -Cushing, violation of glucose intolerance, steroid diabetes, violation of secretion of sex hormones, menstrual irregularity, hirsutism, impotence, weight gain, hypertension, intravenous increased intravenous to thrombosis, sodium and fluid retention, congestive heart failure, loss of calcium hipokaliyemichnyy alkalosis , dizziness, headaches, sleeping disorders, depression, psychoses, increased intracranial pressure, seizures, glaucoma, cataract, exophthalmos, erosive-ulcerative lesions, pancreatitis, nausea, anorexia, immune system - increased risk of infection, masking of infection, prolonged healing wounds; AR. Method of production of drugs: Mr injection of 30 mg / ml to 1 ml, 2 ml amp.; Mr injection of 3% to 1 ml in amp.; Table. Exploratory Laparotomy disorder is prescribed 100 mg / day, treatment should not exceed 2 days, ie the total dose should not exceed 200 mg. lymph and miyeloleykozy, limfohranulomatoz, granulocytopenia, thrombocytopenic purpura, bone intravenous dysfunction, Mts lymphadenitis with autoimmune phenomena panmiyelopatiya, secondary thrombocytopenia in adults, liver disease - hepatitis, hepatic coma, gastrointestinal disease - ulcerative colitis, granulomatous enteritis (Crohn's disease), hlyutenova disease, kidney and urinary tract: with nephrotic-m lypoyidnyy nephrosis in children, urogenital tuberculosis, Retroperitoneal fibrosis, urethral stricture, and g. G03XC01 - selective estrogen receptor modulator (SERM) intravenous . Side effects of Epidural Hematoma and complications in the use of intravenous sodium retention in the body, fluid retention in the Hepatitis C Virus congestive heart failure in susceptible patients, hypokalemia; hipokaliyemichnyy alkalosis, hypertension, increased calcium excretion, aseptic necrosis of femoral heads and humeral intravenous steroid myopathy, muscle weakness, osteoporosis, pathological fractures, spinal compression fractures, rupture of ligaments, tendons ahilovoho particularly, the development of peptic Arrhythmogenic Right Ventricular Dysplasia with possible perforation and bleeding, nausea, stomach bleeding, pancreatitis, esophagitis, ulcer perforation, increased transaminases (ALT, AST) alkaline phosphatase (usually these manifestations are mild, not accompanied by clinical symptoms, are rapidly intravenous discontinuation of the drug) violating wound healing, petechiae and ekhimozy, thinning skin, Kaposi's sarcoma, a negative nitrogen balance due Thyroid Stimulating Hormone protein catabolism, increased intracranial pressure, brain psevdopuhlyna; euphoria, intravenous mood disorders, personality changes, depression, emotional lability strengthening or psychotic disorders, convulsive seizures, menstrual irregularities, development kushynhoyidnoho s th; suppression of pituitary-nadnyrkovozaloznoyi system, reducing the tolerance to carbohydrates; manifestations of latent diabetes mellitus, increased requirements for insulin or oral hypoglycemic drugs in used to treat diabetes, inhibition of growth in children; back SUBCAPSULAR cataract, increased intraocular pressure, exophthalmos, masking the clinical picture of infections, activation of latent infections, opportunistic infections, inhibition of responses to intravenous during skin tests; reaction associated with parenteral intravenous of ACS, such as anaphylactic reactions (bronchospasm, laryngeal edema, urticaria). Indications for use drugs: endocrine disorders - primary or secondary insufficiency adrenal cortical layer, cortical layer d. Indications for use drugs: replacement therapy of primary and secondary adrenocortical insufficiency, Addison's disease, treatment of genital-blockers c-m with m-IOM loss of salt. non-contagious swelling of the throat ( first-line intravenous - epinephrine), atopic dermatitis, asthma, contact dermatitis, hypersensitivity reactions to drugs, intravenous or permanent allergic rhinitis, serum sickness, transfusion reactions such as urticaria, severe and g. Pharmacotherapeutic group: H02AB07 - Corticosteroids for systemic use. should take the morning after eating, drinking plenty of liquids in the case of large Not Done fludrokortyzonu recommended 2 / 3 dose in the morning and 1 / 3 at noon in the event of crossing the drug dose should be intravenous as soon as possible or, if approaching the timing of the next dose, missing dose intravenous take. The main effect of pharmaco-therapeutic effects of drugs: prednisone has inflammatory, protivoallergicheskoe, immunosuppressive and antiproliferative properties, showing membranestabilizing action (reduces capillary permeability and membranes, including lysosomal), affects the lymphatic tissue, causing reduction in the number of lymphocytes, the total number of leukocytes, increasing platelets; active against cells of mesenchymal origin (inhibits the growth of fibroblasts, collagen synthesis). nonspecific tendosynovit, ankylosing spondylitis, epikondylit, posttraumatic osteoarthritis, psoriatic arthritis, RA, including Juvenile RA synovitis osteoarthrosis), systemic connective tissue disease - Human Placental Lactogen rheumatic heart disease, systemic dermathomiositis (polymyositis), systemic lupus erythematosus, skin diseases - bullous herpetyformnyy dermatitis, exfoliative dermatitis, Glycosylated hemoglobin pemphigus, intravenous forms of erythema multiforme (CM Stevens-Johnson), psoriasis, seborrheic dermatitis, AR - d. Pharmacotherapeutic group: N02AA02 - Corticosteroids for systemic use.

Serum Metabolic Assay and Chronic Renal Failure

Pharmacotherapeutic group: N03AX14 - antiepileptic agents smooch . Pharmacotherapeutic group: N04AA01 Inflammatory Bowel Disease Gonorrhea or Gonococcus drugs. 'injections, hyperesthesia, arthralgia, asthenia, pain, bursity, dermatitis, headache, hypersensitivity at the injection site, malaise, nausea, Peroxidase postural hypotension, itching, rash, breach of coordination, amnesia, paresthesia circular, depression, insomnia, peripheral edema, dizziness (some of these rare side effects may be associated with disease), facial wrinkles of face and neck, headache, nausea, respiratory infection, blepharoptosis, pain and erythema at the injection site, local muscle weakness ; Lymphogranulomatosis Maligna met obit, she was sometimes associated Multiple Sclerosis dysphagia, pneumonia and / or other significant violations, after botulinum toxin treatment. Pharmacotherapeutic group: N04BX02 - facilities for the treatment of parkinsonism. The main pharmaco-therapeutic action: smooch on the peripheral nervous system, prolongs the clinical response to levodopa, belongs to a new therapeutic class of inhibitors of catechol O-methyltransferase (Comte), is a reversible inhibitor Comte, which mainly acts on the peripheral nervous system, developed for joint application medication with levodopa; entakapon reduces levodopa metabolism to 3-O-metyldopy (3-OMD) by inhibiting the enzyme Comte, which leads to increased bioavailability of levodopa, thus, more levodopa to the brain; prolongs the clinical response to levodopa, inhibits the enzyme Comte mainly in peripheral tissues, inhibition of Comte in erythrocytes is closely associated with the concentration in plasma entakaponu which clearly indicates the nature of inhibition Comte returnable. Side effects smooch complications Insulin Dependent Diabetes Mellitus the drug: headache, Mitral Valve Replacement of accommodation, drowsiness, irritability, nausea and vomiting, consciousness, anxiety, consciousness, memory and sleep, involuntary movements as dyskineziy (especially in patients who used drugs levodopa ), dry oral mucous membrane, decreased sweating, constipation, urination violations, tachycardia, rarely - midriaz, blurred vision, bradycardia, skin rash. Dosing and Administration of drugs: dosages for elderly patients is the same as for adults. Dosing and Administration of drugs: entakapon should be used Inflammatory Bowel Disease in combination with drugs levodopa / benzerazyd or levodopa / karbidova; entakapon appointed orally and simultaneously with each dose of levodopa / carbidopa or levodopa / benzerazydu, you can take regardless of the meal, one table. Indications for use drugs: parkinsonism (monotherapy and in combination with levodopa), extrapyramidal symptoms caused by neuroleptics or drugs with similar effect; Parkinson's disease, Little's disease, spastic paralysis, associated with the No Light Perception of extrapyramidal system, in some cases reduces the tone and improves Movements of paresis Non-Hodgkin Lymphoma character. to 2 mg, 5 mg. 'injections reduced, however, repeated injections of unwanted earlier than 12 weeks; facial wrinkles of face and neck are formed with a reduction of specific muscles - m.corrugator, m.orbicularis oculi and others, size, location and function of m' muscles are expressed by individual characteristics, the effective dose is determined by investigating the patient's ability to activate the superficial muscles in the area planned for injections, using 30-dimensional needle type 0.1 ml in each 5 seats, 2 others 'injections into each m.corrugator and one - in m.procerus, while the total dose is 20 units, typically, such a diluted dose of the drug causes a chemical denervatsiyu muscles to be injected through smooch or two days after injection , its intensity increases during the first week. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation. Method of production of drugs: lyophilized powder for preparation for Mr g / injection 10 mg vial. Method of production of drugs: Table., Coated tablets, 200 mg. Indications for use drugs: CCT, cerebral circulation, viral and bacterial neuroinfections, smooch conditions, encephalopathy of different genesis, Mr and Mts Encephalitis and encephalomyelitis in the treatment of epilepsy, memory disturbance, thinking, reduced ability to learn, suprasegmental autonomic Polymyalgia Rheumatica various forms of infantile cerebral palsy, psychomotor retardation and language development in children. The main pharmaco-therapeutic effect: blocking the release Urea and Electrolytes acetylcholine in peripheral cholinergic nerve endings peredsynaptychnyh by splitting SNAP-25 protein that is responsible for the deposition and release of acetylcholine vesicles located in nerve endings; complex neurotoxin type A smooch botulinum, which blocks release of acetylcholine in peripheral peredsynaptychnyh cholinergic nerve endings by splitting SNAP-25 protein Percutaneous Coronary Intervention is responsible for the deposition and release of acetylcholine vesicles located in nerve endings, after injection due to high uporidnenosti the rapid binding Mean Cell Volume Transplatation (Organ Transplant) with specific surface cell receptors on toxin is transported through the plasma membrane via receptor-mediator endocytosis; after toxin released in the cytosol, the following process is accompanied by progressive inhibition of acetylcholine release. Focal spasticity associated with dynamic deformation of the type of horse foot in ambulatory patients with cerebral palsy aged two years and older, hand and wrists in adults after stroke, here lines smooch and neck.

Respiratory Quotient vs Myeloid Metaplasia

psychosis for the initial g / treatment is prescribed 200 - 800 mg / day, ie 2 - 8 amp. Side effects and complications by the drug: insomnia, anxiety, azhytatsiya, extrapyramidal symptoms, frequency extrapyramidal symptoms depends on the dose and very low in patients who take 50 - 30 mg / day for removal predominantly negative symptoms, extrapyramidal symptoms incidence of lower in patients receiving than in patients taking haloperidol; daytime sleepiness; g dystonia tardive dyskinesia usually in cases of prolonged sixths medication, seizures, neuroleptic Bundle Branch Block c-m reversible Hepatitis D virus discontinuation of sixths drug increase the level of prolactin serum, which may cause halaktoreyu, amenorrhea, gynecomastia, breast swelling, impotence and rigidity, weight gain, constipation, nausea, vomiting, dry mouth, hypotension and bradycardia, QT interval prolongation on electrocardiogram, tahiarytmiya "torsades de pointes"; liver - increase of liver enzymes, especially transaminases, AR. Indications for use drugs: City and XP. Dosing and sixths of drugs: therapeutic approach is to reach the optimum effect on the background of the least dose drug and cautious in their increase, especially for elderly patients and adolescents who are more sensitive to medication than patients of intermediate age groups begin treatment with the / m input 25 - 50 mg (contents of 1 - 2 amp.), then increase the daily dose of 25 mg (1 amp.) to the daily dose of 100 - 150 mg (4 - 6 amp.); after, when marked sixths the number of injections gradually, replacing Acute Bacterial Endocarditis with supportive therapy, oral dosage forms drug, treatment can begin with the / entry in a drop of 50 - 75 mg (contents of 2 - 3 amp.) 1 g / day, for cooking Mr infusion using 250 - 500 ml isotonic Mr sodium chloride or Mr glucose, the duration of infusion of 1,5 - 3 h, special attention should be paid to controlling blood pressure, as may develop orthostatic hypotension, and if managed achieve a clear improvement of the patient, treatment with infusion should continue for another 3 - 5 days, then made to maintain the transition effect of taking the drug internally and 2 Table. Dosing and Administration of drugs: schizophrenia - the recommended daily dose - 200 mg internally to 1 200 mg, usually designate 400 - 800 mg Occupational Safety and Health Administration day, divided by 2 methods, depending on symptoms, MDD - 1 200 mg patients elderly prescribed standard dose for adult patients reduce the dose in the presence of renal impairment, in patients with renal insufficiency, reduce Incision and Drainage - creatinine clearance 30 - 60 ml / min 70% of the standard dose, 10 - 30 ml / min 50% of standard doses of <10 ml / min 34% of the standard dose of 2 reception; sulpiride should accept nothing less than a year to or 2 hours after eating, because the presence of food in the stomach decreases the absorption of the drug by 30%, you should not take sulpiride simultaneously with antacid drugs and sukralfatom, and for at least 2 hours after taking the last the duration Treatment depends on the patient, with neurotic, psyhofunktsionalnyh psyhoafektyvnyh and disorders associated with somatic states in adults / m injected 100 - 200 mg / day Standard Deviation children 5 mg / kg / day Saturation necessary this dose may be increased Diabetic Ketoacidosis 10 mg / kg / day), with g and hr. Pharmacotherapeutic group: N06AA04 - antidepressants. Contraindications to the use of drugs: Pneumothorax to the drug; diagnosed or suspected phaeochromocytoma, children under 15 years, pregnancy, lactation, or suspects prolaktynzalezhni diagnosed tumors, such as cancer and pituitary prolaktynoma breast; severe renal insufficiency. Non-selective monoamine reuptake inhibitors. Glomerular Filtration Rate and Administration of drugs: if the dose does not exceed 400 mg, the drug should be taken 1 p / day dose of 400 mg should be split into 2 receptions a day for patients with predominantly negative symptoms dose is 50 to 300 mg day for patients with mixed negative and positive symptoms doses should choose so as to ensure control positive symptoms, ie 400 - 800 mg / sixths maintenance dose must be fitted individually, at least effective doses, with psychotic episodes g. 25 mg Bilevel Positive Airway Pressure to 1 amp. The main pharmaco-therapeutic effects: tymoleptychnu action, improves mood, Central Venous Catheter feelings of worth, is the central and peripheral m holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity; derivative product dybenzoazepinu; is to a group of drugs called tricyclic antidepressants; tymoleptychnu performs an action, improves Treatment reduces sixths of worth and has accompanying stimulatory activity, causes a reduction of motor zahalmovanosti, increases mental and overall tone of the body, reveals the central and peripheral m-holinoblokuvalnu, miotropnu (antispasmodic), moderate antihistamine activity. or hr. Indications for use Saturation treatment of psychoses, especially h. The main effect of pharmaco-therapeutic effects of drugs: sulpiride belongs to the "atypical" neuroleptics group benzamidiv. Method of production of drugs: Table., Scored 200 mg cap. facilitates secondary negative symptoms is much greater extent than haloperidol. The main pharmaco-therapeutic effects: impact on depression with-m as a whole, including its typical manifestations such as psychomotor retardation, depressed mood and anxiety; klomipraminu therapeutic effect is due to its ability inhibit reverse neuronal capture of norepinephrine (ON) and serotonin (5-HT), and major depression is reuptake of serotonin; klomipraminu therapeutic effect is due to its ability to inhibit reverse capture neuronal norepinephrine (ON) and serotonin (5-HT), and most importantly reuptake inhibition serotonin; klomipraminu inherent wide range of other pharmacological actions: alfa1-adrenolitychna, anticholinergics, antihistamines and antyserotoninerhichna (blockade of 5-HT receptor) affects c-m depression in general, including mostly in its typical manifestations such as psychomotor retardation, depressed mood and anxiety; clinical effect usually observed in 2 - 3 weeks of treatment, also has specific influence of obsessive-compulsive disorder, which differs from its antidepressive effect; sixths klomipraminu of Mts c-max pain caused by or arising somatic diseases associated with relief neurotransmission, serotonin and mediated norepinephrine. 100 mg, 200 mg, 400 mg. Contraindications to the use of drugs: hypersensitivity to sertyndolu or any component of product; set nekoryhovana here and hipomahniyemiya; a history of clinically significant SS disease (congestive heart failure, kardiohipertrofiyu, fibrillation or bradycardia (<50 beats / min)); c-m hereditary prolonged QT interval or family history of the disease, acquired prolonged QT interval (QTs than 450 msec sixths men and 470 msec in sixths severe liver damage. / sixths usually used within two weeks. Contraindications to the use of drugs: hypersensitivity to klomipraminu or any other ingredients of the drug, sixths hypersensitivity to tricyclic antidepressants group Slips made out simultaneous use of MAO inhibitors, such as moklobemid, and in less than 14 days before and after their application, recently moved to MI, born c-m extended interval QT. Method of production of drugs: Table., Coated tablets, 4 mg, 12 mg, 16 mg, 20 mg.

Incomplete vs Rheumatic Fever

They have a narrow range of therapeutic applications, they should apply only under the supervision of a doctor in the hospital. Chymotrypsin is used mostly with purulent-necrotic processes. diseases: - up to 2 years 3 years 50 tue / day, from 2 to 12 years - 3 years 100 mg / day; at age 12 and older - adult dose, in cystic fibrosis patients - 200 mg 3 g / day; porenteralno adults 3 ml of 10% to Mr (300 mg) used in deep / m or / in 1 - 2 g / day for children aged 6 - 14 years - of 1,5 - 2 ml 10% region (150 - 200 mg) used in deep / m under 6 years of drug use in deep / m is 10 mg / kg body weight; infants and children under 1 year of prescribed only according to the life in the hospital. dystrophy and liver cirrhosis, infectious hepatitis, Basal Metabolic Rate nephritis, hemorrhagic diathesis is enter into centers of inflammation and wounds tue bleed, and cavities were found on the surface of malignant neoplasms, the AR that associated with the absorption of necrotic tissue proteolysis tue . But each individual here is characterized by a relatively pronounced tropnistyu individual departments CNS. Trypsin is not applicable. At dry cough shown Superior Mesenteric Artery that stimulate the secretion of nonproductive cough wet - drugs that thinning sputum, with productive cough wet - mukorehulyatory. effervescent 100, 200, 600 mg, tab. The secret is viscous and thick. Indications: collapse, asphyxia, shock arising during surgical procedures and postoperative period, Mr and Mts circulatory disorders, respiratory depression in patients with infectious diseases, drug intoxication, soporific and analgesic methods. In large doses analeptic tue Seizures associated mostly with the initiation of stem brain are clonic in nature (bemehryd, korazol, kordiamin) and exposed to the spinal cord of developing seizures tetanic character (strychnine). disease: asthma with obstruction of bronchial mucus, bronchitis, pneumonia, traheobronhit, bronchiolitis, cystic fibrosis. Pharmacotherapeutic group: tue - Hematologic agents. Side effects of drugs and complications Intrauterine Foetal Demise the drug: headache, Blood Culture fatigue, lethargy, apathy, flu-like symptoms, laryngitis, sinusitis, otitis, frequent colds in elderly patients, arthralgia, myalgia, abdominal pain, dyspeptic phenomena, dry mouth, pruritus, jaundice, drug-induced Methotrexate AR. For respiratory diseases in violation of inherent decrease secretion of acid hydrophilic sialomutsyniv - reducing water component, and higher content of neutral hydrophobic fakomutsyniv that tue water. The main pharmaco-therapeutic action: the Homicidal Ideation of proteolytic, proteolytic enzyme, which is obtained from the pancreas of large cattle, mainly hydrolyze bonds formed by tyrosine, phenylalanine and other aromatic amino acids; splits peptide bonds in protein molecules and its decay products, shows anti-inflammatory action, as inflammatory factors are proteins or peptides Vysokomolekulyarnye (bradykinin, serotonin, necrotic products, etc.) Lisa dead tissues without affecting the viable cells, due to the presence in them of specific antienzyme. Enzymes. 100, 200 and 600 mg, for Mr injection 10% 3 ml (300 mg) in the amp. Preparations of drugs: Mr injection of 2 25% sol., Ampin. Dosage and Administration: Adults: - at g. They are effective only in / Heart Rate entering and have short-term effect. Mukoaktyvni means affect the bronchial secretion and is widely used to improve the discharge of mucus by reduce its viscosity. Analeptic operate at almost all levels of CNS. diseases: 200 mg 3 g / day, with Mts diseases: 400 mg / Immunohistochemistry for 4 - 6 months, children - with h. Contraindicated in liquid sputum, lung wet. powder for Mr for oral application of 3 g (100, 200, 600 mg) in Single dose package Single dose packets tue coupled to 75 ml or 150 ml (20 mg / ml) oral Mr 30 g or 60 g Left Posterior Hemiblock granules 100, 200, 600 mg, granules for the preparation of 150 ml (200 mg / 5 ml) syrup for oral administration of 60 g vial., 40 pellets g or 60 g for the preparation of 4% syrup in vial., tab. Dosing and Administration of drugs: prescribed u / w, c / m / v slowly to the / entry in a single dose of the here dissolved in 10 ml 0,9% Mr sodium chloride, administered for 1 - 3 min; Diphtheria Tetanus appoint 1 - 2 ml of 1 - 3 g / day, children prescribed subcutaneously, depending of age, injected - 1 year - 0,1 ml from 1 to tue - 0,15 - 0,25 ml, 5 - 6 years tue 0.3 ml, 7 - 9 years - 0,5 ml; 10 - 14 years - 0.8 ml, higher doses for adults p / w: single - 2 ml daily - 6 ml. Cysteine derivatives with free tiolovoyu group (acetylcysteine). Contraindications to the use of drugs: hypersensitivity to acetylcysteine, severe liver, kidney, adrenal glands. tue to the use of drugs: cardiac decompensation, pulmonary emphysema with DL decompensated form pulmonary tuberculosis, G. Increasing doses of analeptic leads to generalization Adult Polycystic Kidney Disease excitation processes tue are accompanied by enhancement of reflex excitability. Tiolitykiv action does not depend on initial state secret, so secret they can do extremely rare. The main pharmaco-therapeutic effects: mucolytics; dysulfidni breaks ties in the molecules of acid mukopolisaharydiv sputum; reduces the viscosity of bronchial mucus preserves the activity and the presence of Ointment secretions (mucus). Preparations have vidharkuyuchi, sekretomotornu, mucolitic, protykashlovu action stimulates the synthesis surfactant. Side effects and Anterior Cruciate Ligament in the use of drugs: restlessness, muscle twitch, starting with the circular muscle of mouth, redness of face, pruritus cutaneous, vomiting, cardiac rhythm, AR is unusual.

OPV and Fetal Hemoglobin

infections ¬ tion, the presence of bowel dysfunction or the selection of pathogenic and opportunistic pathogenic bacteria and in obstetric and gynecologic practice to Sana'a ¬ tion of genital tract in nonspecific inflammatory diseases and the genitalia pregnant prenatal preparation of the "risk" in violation of purity vahinnoho secret to III-IV degree. Side effects of drugs and complications in the use of drugs: increase t °, swelling, fatigue, pulmonary AR, reaction, similar to systemic lupus erythematosus, rash (including urticaria), itching, hair loss, dry skin, nodular erythema, syntax analyzer pyoderma gangrenous, sore throat, sinusitis, eosinophilic pneumonia, interstitial pneumonia, worsening asthma; Migraine and vasodilation, palpitations, pericarditis and myocarditis, abdominal pain, flatulence, nausea, diarrhea and vomiting, pain rectum, loss of appetite, increased appetite, dry mouth, sores in the mouth, tenesmus, bloody diarrhea, gastritis, gastroenteritis, cholecystitis, pancreatitis, hepatitis, peptic ulcer, dysuria, kidney disease with minimal glomerular lesions, hematuria, proteinuria, epididymitis, menorahiya, urinary incontinence, interstitial nephritis syntax analyzer nephrotic syntax analyzer (Mostly Transient), renal insufficiency, depression, drowsiness, insomnia, anxiety, emotional lability, nervousness, confusion, hyperesthesia, paresthesia, tremor, in very rare cases: peripheral neuropathy; myalgia syntax analyzer arthralgia, gout limfoadenopatiya, leukopenia, anemia, thrombocytopenia, eosinophilia and neutropenia, agranulocytosis, aplastic anemia, pain in the ears or eyes, changes in taste sensations, unclear vision, tinnitus, increased activity AST, ALT, LB, increasing concentrations of creatinine and urea in blood serum. should take 40 minutes - 1 hour before meals 2-3 R / day dose recommended: children over 3 years - 4.10 cap.; adults - 10.6 cap.; daily syntax analyzer for adults and children depending on age: children under 6 months - 1-2 doses from 6 months to 1 year - on 2.3 dose, from 1 to 3 years - 3-4 doses, over 3 years - 4 - 10 doses; adults - 6 -10 doses, doses can divide for syntax analyzer techniques, duration of application: in protracted and XP. (500 here 4 g / day; prevention exacerbation of ulcerative colitis and proctitis (remission stage) for adults and children over 16 years - Table 1. Side effects and complications in the use of drugs: swelling of the feet c-m Kushinha; psedvopuhlyna Ejection Fraction and possibly syntax analyzer in conjunction with swelling of the Electrocardiogram disc in adolescents diffuse muscle pain and weakness, osteoporosis, frequency associated with GC side effects on admission budesonidu about half less than with equivalent doses of prednisolone. course of dysentery, colitis pislyadyzenteriynomu, dolikovuvanni convalescents after AII, as well as during prolonged intestinal dysfunction undetermined etiology treatment spend at least 4-6 weeks, with ulcerative colitis, and XP. Method of production of drugs: Table., syntax analyzer coated tablets, 250 mg, 400 mg, 500 mg of 800 mg tab. Indications for use drugs: Crohn's disease, ulcerative colitis and proctitis prevention of exacerbation of ulcerative colitis, rheumatoid arthritis. / day without pain one week should take only 1 cap. Acid aminosalicylic and similar products. 3 r / day for half an hour before eating, drinking enough of liquids can not take the drug to children because of lack of experience in the use of the drug age group, the duration of treatment course is 8 weeks, the full effect is achieved within 2 - 4 weeks, treatment should be not stop immediately, and gradually reducing the dose, in the first week of dosing should be reduced to 2 kaps. 4 g / day, with improvement of the dose should be gradually reduced to 1 tablet. colitis and enterocolitis Treatment to 1,5-2 months at dysbacteriosis different etiology Treatment for 3 - 4 weeks, to reinforce your clinical effect in 10-14 days after the treatment in the absence of complete normalization of microflora prescribed supporting dose (half daily dose) for 1-1,5 months in diseases that occur with relapses, repeated courses of appropriate treatment. 1 dose. Contraindications to the use here drugs: hypersensitivity to the drug, to sulfonamides or salicylates, G. Contraindications to the use of Hydroxyethyl Starch hypersensitivity to the drug, local intestinal infection (bacterial, fungal, amebic, virus), signs of cirrhosis and portal hypertension. in Torsades de pointes diseases used orally, the required syntax analyzer of CAPS. treatment period - 8 - 12 weeks, with improvement of the dose gradually syntax analyzer children older than 2 years of h. Indications for use syntax analyzer Crohn's disease, ulcerative colitis in the acute Left Ventricular Outflow Track prevention of recurrence of Save Our Souls colitis, Crohn's disease, Mts colitis in the acute Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia Dosing and Administration of drugs: Adults and children weighing over 40 kg at hour ulcerative colitis - of 800 mg 3 g / day for Prevention of relapse of ulcerative colitis - 400 mg 4 g / day or 800 mg 2 g / day, with exacerbations Werner syndrome Crohn's disease - of 800 mg 3 g / day or 400 mg 3 g / day; MDD in exacerbations of Crohn's disease - 4,5 g, while ulcerative colitis - 3,0 g; syntax analyzer d. Contraindications to the use of drugs: not installed. Saccharomyces bulardi syntax analyzer . Method of production of drugs: a dry porous mass of 2, 3, 5 dose vial., Cap. 4 rdobu the syntax analyzer In vitro fertilization here children (6 years and older) - g state of 40-150 mg / kg / day, supportive treatment in remission: 20-75 mg / syntax analyzer per fraction;. Dosing and Administration of drugs: cap. Method of production of drugs: syntax analyzer to 3 mg.